Biocon Biologics launches stelara biosimilar YESINTEK in US for autoimmune diseases
Shares of Biocon Ltd ended at ₹321.30, down by ₹0.75, or 0.23% on the BSE.

Shares of Biocon Ltd ended at ₹321.30, down by ₹0.75, or 0.23% on the BSE.
What's Your Reaction?






